Flagship explainer
What drives Krystal Biotech, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $205M | FY2025 |
| |
| Income before tax | $189M | FY2025 |
|
| Operating income | $161M | FY2025 |
|
| $389M | FY2025 |
| |
| Ending assets | $1.3B | FY2025 |
|
| Beginning assets | $1.1B | FY2024 |
|
| $1.2B | FY2025 |
| |
| $946M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001711279-26-000016